| Research collaboration at a distance: Changing spatial patterns of scientific collaboration within Europe J Hoekman, K Frenken, RJW Tijssen Research Policy 39 (5), 662-673, 2010 | 765 | 2010 |
| The geography of collaborative knowledge production in Europe J Hoekman, K Frenken, F Van Oort The annals of regional science 43, 721-738, 2009 | 533 | 2009 |
| Spatial scientometrics: Towards a cumulative research program K Frenken, S Hardeman, J Hoekman Journal of informetrics 3 (3), 222-232, 2009 | 400 | 2009 |
| Drug-induced reduction in albuminuria is associated with subsequent renoprotection: a meta-analysis HJL Heerspink, TF Kröpelin, J Hoekman, D De Zeeuw Journal of the American Society of Nephrology 26 (8), 2055-2064, 2015 | 229 | 2015 |
| Big Pharma, Little Science? A bibliometric perspective on big pharma’s R&D decline I Rafols, M Hopkins, J Hoekman, P Nightingale, A Perianes-Rodriguez, ... Technological Forecasting and Social Change, 2012 | 213 | 2012 |
| Adverse drug reaction reporting in Africa and a comparison of individual case safety report characteristics between Africa and the rest of the world: analyses of spontaneous … HH Ampadu, J Hoekman, ML de Bruin, SN Pal, S Olsson, D Sartori, ... Drug safety 39, 335-345, 2016 | 208 | 2016 |
| Acquisition of European research funds and its effect on international scientific collaboration J Hoekman, T Scherngell, K Frenken, R Tijssen Journal of economic geography 13 (1), 23-52, 2013 | 148 | 2013 |
| What drives university research performance? An analysis using the CWTS Leiden Ranking data K Frenken, GJ Heimeriks, J Hoekman Journal of informetrics 11 (3), 859-872, 2017 | 144 | 2017 |
| Challenges in advanced therapy medicinal product development: a survey among companies in Europe RMT Ten Ham, J Hoekman, AM Hövels, AW Broekmans, HGM Leufkens, ... Molecular Therapy Methods & Clinical Development 11, 121-130, 2018 | 123 | 2018 |
| Death of distance in science? A gravity approach to research collaboration K Frenken, J Hoekman, S Kok, R Ponds, F van Oort, J van Vliet Innovation networks: New approaches in modelling and analyzing, 43-57, 2009 | 81 | 2009 |
| Use of the conditional marketing authorization pathway for oncology medicines in Europe J Hoekman, WPC Boon, JC Bouvy, HC Ebbers, JP de Jong, ML De Bruin Clinical Pharmacology & Therapeutics 98 (5), 534-541, 2015 | 79 | 2015 |
| Characteristics and follow‐up of postmarketing studies of conditionally authorized medicines in the EU J Hoekman, TT Klamer, AK Mantel‐Teeuwisse, HGM Leufkens, ... British journal of clinical pharmacology 82 (1), 213-226, 2016 | 68 | 2016 |
| The geography of scientific citations ML Wuestman, J Hoekman, K Frenken Research Policy 48 (7), 1771-1780, 2019 | 62 | 2019 |
| Spatial scientometrics and scholarly impact: A review of recent studies, tools, and methods K Frenken, J Hoekman Measuring scholarly impact: methods and practice, 127-146, 2014 | 52 | 2014 |
| The Geographical Distribution of Leadership in Globalized Clinical Trials J Hoekman, K Frenken, D de Zeeuw, HL Heerspink PLOS ONE 7 (10), e45984, 2012 | 52 | 2012 |
| What does cell therapy manufacturing cost? A framework and methodology to facilitate academic and other small-scale cell therapy manufacturing costings RMT Ten Ham, AM Hövels, J Hoekman, GWJ Frederix, HGM Leufkens, ... Cytotherapy 22 (7), 388-397, 2020 | 51 | 2020 |
| Organizational capacities of national pharmacovigilance centres in Africa: assessment of resource elements associated with successful and unsuccessful pharmacovigilance experiences HH Ampadu, J Hoekman, D Arhinful, M Amoama-Dapaah, HGM Leufkens, ... Globalization and health 14, 1-17, 2018 | 51 | 2018 |
| The importance of geographical distance to different types of R&D collaboration in the pharmaceutical industry F Bignami, P Mattsson, J Hoekman Industry and Innovation 27 (5), 513-537, 2020 | 50 | 2020 |
| Does conditional approval for new oncology drugs in Europe lead to differences in health technology assessment decisions? I Lipska, J Hoekman, N McAuslane, HGM Leufkens, AM Hövels Clinical Pharmacology & Therapeutics 98 (5), 489-491, 2015 | 50 | 2015 |
| Convergence in an enlarged Europe: the role of network cities. K Frenken, J Hoekman Tijdschrift voor Economische en Sociale Geografie (Journal of Economic …, 2006 | 50 | 2006 |
Koen FrenkenFull Professor in Innovation Studies, Utrecht University在 uu.nl 的電子郵件地址已通過驗證
Marie L De BruinAssistant Professor, Utrecht University在 uu.nl 的電子郵件地址已通過驗證
Dick de ZeeuwEmeritus Professor Clinical Pharmacology, University of Groningen, University Medical Center在 umcg.nl 的電子郵件地址已通過驗證
Hiddo Lambers HeerspinkUniversity of Groningen在 umcg.nl 的電子郵件地址已通過驗證
Robert TijssenProfessor emeritus of Science and Innovation Studies, Leiden University; Stellenbosch University在 cwts.leidenuniv.nl 的電子郵件地址已通過驗證
Wouter BoonInnovation Studies Groups, Utrecht University在 uu.nl 的電子郵件地址已通過驗證
Pieter StolkUtrecht University在 uu.nl 的電子郵件地址已通過驗證hans c. ebbersUtrecht University在 uu.nl 的電子郵件地址已通過驗證
Gaston HeimeriksInnovation Studies, Copernicus Institute of sustainable development at Utrecht University在 uu.nl 的電子郵件地址已通過驗證
Ismael RafolsINGENIO (CSIC-UPV), UNESCO Chair in Diversity and Inclusion, CWTS at Univ. Leiden,在 cwts.leidenuniv.nl 的電子郵件地址已通過驗證
Paul NightingaleSussex在 sussex.ac.uk 的電子郵件地址已通過驗證
Michael M HopkinsProfessor of Innovation Management, SPRU, University of Sussex Business School在 sussex.ac.uk 的電子郵件地址已通過驗證
Diederick E. GrobbeeProfessor of Clinical Epidemiology, University Medical Center Utrecht在 umcutrecht.nl 的電子郵件地址已通過驗證
Thomas ScherngellResearcher, AIT Austrian Insitute of Technology在 ait.ac.at 的電子郵件地址已通過驗證